Advertisement
Home Tags CORO

Tag: CORO

La vacuna de Pfizer contra la COVID parece promisoria

One-Third of U.S. Adults Likely to Refuse a COVID-19 Vaccine

Blacks, women, and conservatives more hesitant in the United States

HealthDay Reports: New Coronavirus Strain More Contagious

Stem Cell Infusions Investigated for Treatment of COVID-19 ARDS

Researchers explore possible anti-inflammatory effects of mesenchymal stem cells in COVID-19 acute respiratory distress syndrome

HealthDay Reports: Test of 10 Million in Wuhan Finds Few Infections

WHO Experts Finally Arrive in Wuhan for COVID-19 Investigation

First known cases of the novel coronavirus appeared in the city more than a year ago

COVID-19 Infection Higher Among Support Staff Than Doctors

CDC Describes COVID-19 Trends in Nursing Home Residents, Staff

Rates of COVID-19 increased during June and July, followed by decline through mid-September, increase by late November

B1/15 - Masks

College Campuses at Risk for Extreme Incidence of COVID-19

Colleges rapidly reduced the number of new infections, but many failed to control the spread beyond the campus

New Insights Into How COVID-19 Damages the Brain

Multifocal Microvascular Injury ID’d in Brain in COVID-19

No SARS-CoV-2 detected in postmortem samples, but brain may be susceptible to microvascular damage

HealthDay Reports: CDC Issues Call to Reopen America's Schools This Fall

Incidence of COVID-19 Increased in Children Since September

Trends for children tracked consistently with those of adults; incidence lower for children aged 0 to 10 years

One-Dose Covid-19 Vaccine From Johnson & Johnson Looks Promising

U.S. COVID-19 Vaccine Rollout Nears 1 Million Doses Per Day

News comes as Ohio State University researchers discover new variant of COVID-19 virus

HealthDay Reports: Black Americans Appear Most Vulnerable to Coronavirus

DKA Common in Blacks With T1DM and Confirmed COVID-19

Non-Hispanic Blacks with T1DM and COVID-19 have nearly fourfold increased odds of presenting with diabetic ketoacidosis

La vacuna de Pfizer contra la COVID parece promisoria

Ad26.COV2-S Vaccine Seems Safe, Immunogenic for SARS-CoV-2

Neutralizing antibodies detected in 90 percent or more of all participants on day 29 after the first vaccine dose